The Cancer Letter
Shop All The Cancer Letter Browse by category All Items Mugs Prints Shop All 4 results Shop All The Cancer Letter mug $16.00 – $20.50 Diversity, Equity, Inclusion print $22.00 – $34.00 Evidence-based guidelines print $22.00…
Shop All The Cancer Letter Browse by category All Items Mugs Prints Shop All 4 results Shop All The Cancer Letter mug $16.00 – $20.50 Diversity, Equity, Inclusion print $22.00 – $34.00 Evidence-based guidelines print $22.00…
Yosemite, an oncology-focused venture capital firm, and the American Cancer Society established the Yosemite-American Cancer Society Award with an initial commitment of $13.2 million. To…
Tempus has sent de-identified tumor profiles with limited associated clinical information from more than 3,000 cancer diagnoses to the NCI. To access this subscriber-only content…
We had the privilege of working with Norm Coleman in the International Cancer Expert Corps (ICEC), the NGO he founded in 2013 and where he…
In a paper published in The Lancet Public Health, researchers sound a clarion call for greater investment, at both the community and institutional level, in…
The FDA Oncologic Drugs Advisory Committee voted overwhelmingly in favor of expanding the indications of two chimeric antigen receptor engineered T-cell therapies for multiple myeloma…
Matthew Carpenter, co-leader of the Cancer Control Research Program at MUSC Hollings Cancer Center and the Flora McLeod Edwards Distinguished Endowed Chair in Cancer Research,…
Soon after he was diagnosed with a dedifferentiated liposarcoma, C. Norman Coleman reached out to The Cancer Letter and the Cancer History Project to initiate…
A study led by USC Norris Comprehensive Cancer Center, part of the Keck School of Medicine of USC, analyzed data on red and processed meat…
The FDA Oncologic Drugs Advisory Committee voted overwhelmingly in favor of expanding the indications of two chimeric antigen receptor engineered T-cell therapies for multiple myeloma…
Addressing the NCI Board of Scientific Advisors, Institute Director Kimryn Rathmell announced two key initiatives—the Cancer Screening Research Network and the Virtual Clinical Trials Office—designed…